Updated Apr 29, 2016 12:40 PM ET
Prior Close: $76.46
The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.
We produce five unique ratings, including the Zacks Style Score, which combines the individual style scores into 1 rating:
|Zacks Style Score||A|
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a score of an A or a B in your personal trading style.
Zacks Scorecard Education - Learn more about the Zacks Scorecard
The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.
The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.
As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.
Zacks Style Scores Education - Learn more about the Zacks Style Scores
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
|Zacks Rank||Definition||Annualized Return|
Zacks Rank Education - Learn about the Zacks Rank
Zacks Rank Home - Zacks Rank resources in one place
Zacks Premium - The way to access to the Zacks Rank
The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.
The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.
The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.
Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.
Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
LILLY ELI & CO
LILLY CORPORATE CTR DROP CODE 1112
INDIANAPOLIS, IN 46285
|Industry||LARGE CAP PHARMA|
|Fiscal Year End||December|
|Last Reported Quarter||3/31/2016|
|Next EPS Date||7/28/2016|
|Current Quarter EPS Consensus Estimate||0.85|
|Current Year EPS Consensus Estimate||3.56|
|Estimated Long-Term EPS Growth Rate||11.80|
|Next EPS Report Date||7/28/2016|
Price and Volume Information
|52 Week High||92.85|
|52 Week Low||67.88|
|20 Day Moving Average||3,604,510.50|
|Target Price Consensus||94.58|
|Shares Outstanding (millions)||1,104.49|
|Market Capitalization (millions)||84,449.46|
|Last Split Date||10/16/1997|
|Change in Payout Ratio||NA|
|Last Dividend Payout / Amount||2/10/2016 / $0.51|
|Trailing 12 Months||22.49|
|vs. Previous Year||-4.60%|
|vs. Previous Quarter||6.41%|
|vs. Previous Year||4.75%|
|vs. Previous Quarter||-9.50%|
|Price / Sales||4.18|